Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe
Päivi Lähteenmäki; Thomas Wiebe; Nadia Haddy; Edit Bárdi; Rahel Kuonen; David L Winter; Momcilo Jankovic; Miranda M Fidler; Rodrigue S Allodji; Lars Hjorth; Giao Vu-Bezin; Roderick Skinner; Hilde Øfstaas; Peter Kaatsch; Stanislaw Garwicz; Jop C Teepen; Monica Terenziani; Andrea Bautz; Zsuzsanna Jakab; Carlotta Sacerdote; Florent de Vathaire; Julianne Byrne; Desiree Grabow; Thorgerdur Gudmundsdottir; Claudia E Kuehni; Finn Wesenberg; Daniela Alessi; Raoul C Reulen; The PanCareSurFup Consortium; Helena Linge; Francesca Bagnasco; Leontien C Kremer; Chloe J Bright; Jeanette F Winther; Riccardo Haupt; Mike M Hawkins; Joyeeta Guha; Lorna Zadravec Zaletel; Cecile M Ronckers; Elizabeth A M Feijen; Melanie Kaiser
Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe
Päivi Lähteenmäki
Thomas Wiebe
Nadia Haddy
Edit Bárdi
Rahel Kuonen
David L Winter
Momcilo Jankovic
Miranda M Fidler
Rodrigue S Allodji
Lars Hjorth
Giao Vu-Bezin
Roderick Skinner
Hilde Øfstaas
Peter Kaatsch
Stanislaw Garwicz
Jop C Teepen
Monica Terenziani
Andrea Bautz
Zsuzsanna Jakab
Carlotta Sacerdote
Florent de Vathaire
Julianne Byrne
Desiree Grabow
Thorgerdur Gudmundsdottir
Claudia E Kuehni
Finn Wesenberg
Daniela Alessi
Raoul C Reulen; The PanCareSurFup Consortium
Helena Linge
Francesca Bagnasco
Leontien C Kremer
Chloe J Bright
Jeanette F Winther
Riccardo Haupt
Mike M Hawkins
Joyeeta Guha
Lorna Zadravec Zaletel
Cecile M Ronckers
Elizabeth A M Feijen
Melanie Kaiser
Oxford University Press
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042823954
https://urn.fi/URN:NBN:fi-fe2021042823954
Tiivistelmä
Childhood cancer survivors are at risk of subsequent primary soft-tissue sarcomas (STS), but the risks of specific STS histological subtypes are unknown. We quantified the risk of STS histological subtypes after specific types of childhood cancer.\nWe pooled data from 13 European cohorts, yielding a cohort of 69 460 five-year survivors of childhood cancer. Standardized incidence ratios (SIRs) and absolute excess risks (AERs) were calculated.
Overall, 301 STS developed compared with 19 expected (SIR = 15.7, 95% confidence interval [CI] = 14.0 to 17.6). The highest standardized incidence ratios were for malignant peripheral nerve sheath tumors (MPNST; SIR = 40.6, 95% CI = 29.6 to 54.3), leiomyosarcomas (SIR = 29.9, 95% CI = 23.7 to 37.2), and fibromatous neoplasms (SIR = 12.3, 95% CI = 9.3 to 16.0). SIRs for MPNST were highest following central nervous system tumors (SIR = 80.5, 95% CI = 48.4 to 125.7), Hodgkin lymphoma (SIR = 81.3, 95% CI = 35.1 to 160.1), and Wilms tumor (SIR = 76.0, 95% CI = 27.9 to 165.4). Standardized incidence ratios for leiomyosarcoma were highest following retinoblastoma (SIR = 342.9, 95% CI = 245.0 to 466.9) and Wilms tumor (SIR = 74.2, 95% CI = 37.1 to 132.8). AERs for all STS subtypes were generally low at all years from diagnosis (AER < 1 per 10 000 person-years), except for leiomyosarcoma following retinoblastoma, for which the AER reached 52.7 (95% CI = 20.0 to 85.5) per 10 000 person-years among patients who had survived at least 45 years from diagnosis of retinoblastoma.\nFor the first time, we provide risk estimates of specific STS subtypes following childhood cancers and give evidence that risks of MPNSTs, leiomyosarcomas, and fibromatous neoplasms are particularly increased. While the multiplicative excess risks relative to the general population are substantial, the absolute excess risk of developing any STS subtype is low, except for leiomyosarcoma after retinoblastoma. These results are likely to be informative for both survivors and health care providers.
Kokoelmat
- Rinnakkaistallenteet [19207]